This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Alpha-GPC
Alpha-GPC is a highly bioavailable choline compound that crosses the blood-brain barrier, supporting acetylcholine synthesis for cognitive function, memory, and physical performance. Clinical evidence supports benefits in age-related cognitive decline.
Benefits
What is Alpha-GPC?
Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a naturally occurring choline compound found in small quantities in organ meats, dairy products, and wheat germ. It contains 41% choline by weight, making it one of the most efficient choline sources available. Unlike many other choline donors, Alpha-GPC readily crosses the blood-brain barrier.
Clinical research has primarily focused on its role in age-related cognitive decline. A 2023 systematic review and meta-analysis of seven RCTs involving over 4,000 patients demonstrated significant improvements in cognitive function in patients with dementia. More recent studies have shown acute cognitive benefits in healthy young men.
Emerging safety concerns warrant attention: a large-scale 10-year cohort study found a dose-responsive association between Alpha-GPC use and increased stroke risk, potentially mediated through gut-microbiome-driven conversion to TMAO.
- Acetylcholine Precursor: Cleaved to release free choline, which crosses the blood-brain barrier and is converted to acetylcholine via choline acetyltransferase.
- Phosphatidylcholine Synthesis: The glycerophosphate moiety enters the Kennedy pathway to synthesise phosphatidylcholine, supporting neuronal membrane integrity.
- Dopaminergic Modulation: Increases dopamine release and DAT expression in the frontal cortex, influencing motivation and mood.
- Growth Hormone Secretion: A single 600 mg dose before exercise augments post-exercise growth hormone release.
- Neuroprotective Effects: Suppresses microglial activation and sustains hippocampal neurogenesis in animal models.
- Cognitive Support: 300–600 mg per day, split into 1–2 doses.
- Cognitive Decline (Clinical): 1,200 mg per day (400 mg three times daily) for 3–6 months.
- Athletic Performance: 300–600 mg taken 30–90 minutes before exercise.
Best taken with food. Due to potential energising effects, evening dosing may interfere with sleep.
- Common Side Effects: Headache, heartburn, nausea, diarrhoea, and insomnia.
- TMAO and Cardiovascular Risk: Can be metabolised by gut bacteria to produce TMAO, associated with increased atherosclerosis risk.
- Stroke Risk: A 10-year cohort study of 12 million subjects found dose-responsive higher stroke risk (observational, causation not established).
- Drug Interactions: May interact with anticholinergic medications and acetylcholinesterase inhibitors.
Short-term safety profile is favourable (up to 6 months at 1,200 mg/day). Long-term high-dose use should be approached with caution.
Natural Sources & Forms
- Organ Meats and Eggs: Richest natural dietary sources of choline.
- Dairy and Fish: Moderate levels of glycerophosphocholine.
- Supplement Forms: Capsules (150–600 mg) derived from soya lecithin. Common branded form: AlphaSize.
Research Studies
The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort
Poly C, Massaro JM, Seshadri S, Wolf PA, Cho E, Krall E, Jacques PF, Au R - American Journal of Clinical Nutrition
Higher choline intake is associated with better memory performance and healthier brain structure in adults.
Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type
Parnetti L, Abate G, Bartorelli L, Cucinotta D, Cuzzupoli M, Maggioni M, Villardita C, Senin U - Drugs and Aging
Alpha-GPC (1200mg daily) significantly improved cognition and functioning in Alzheimer's patients over 180 days.
Frequently Asked Questions
Alpha-GPC is a highly bioavailable choline compound that crosses the blood-brain barrier, supporting acetylcholine synthesis for cognitive function, memory, and physical performance. Clinical evidence supports benefits in age-related cognitive decline.
The key benefits of Alpha-GPC include: Cognitive Enhancement, Energy, Focus, Longevity, Memory, Mood, Motivation.
Acetylcholine Precursor: Cleaved to release free choline, which crosses the blood-brain barrier and is converted to acetylcholine via choline acetyltransferase. Phosphatidylcholine Synthesis: The glycerophosphate moiety enters the Kennedy pathway to synthesise phosphatidylcholine, supporting neuronal membrane integrity. Dopaminergic Modulation: Increases dopamine release and DAT expression in the frontal cortex, influencing motivation and mood. Growth Hormone Secretion: A single 600 mg dose before exercise augments post-exercise growth hormone release. Neuroprotective Effects: Suppresses microglial activation and sustains hippocampal neurogenesis in animal models.
Cognitive Support: 300–600 mg per day, split into 1–2 doses. Cognitive Decline (Clinical): 1,200 mg per day (400 mg three times daily) for 3–6 months. Athletic Performance: 300–600 mg taken 30–90 minutes before exercise. Best taken with food. Due to potential energising effects, evening dosing may interfere with sleep.
Common Side Effects: Headache, heartburn, nausea, diarrhoea, and insomnia. TMAO and Cardiovascular Risk: Can be metabolised by gut bacteria to produce TMAO, associated with increased atherosclerosis risk. Stroke Risk: A 10-year cohort study of 12 million subjects found dose-responsive higher stroke risk (observational, causation not established). Drug Interactions: May interact with anticholinergic medications and acetylcholinesterase inhibitors. Short-term safety profile is favourable (up to 6 months at 1,200 mg/day). Long-term high-dose use should be approached with caution.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!